PSMA expression levels, which are associated with androgen signaling, can significantly influence the efficacy of PSMA-targeted therapies, positioning PSMA as a promising target for innovative prostate cancer treatments [33]. The gene discussed is FOLH1; the disease is Familial prostate cancer.